You are here: Industry Insights > Diabetes

News List

Primary Care Use Aids Patients With Diabetes and Coexisting Psych Disorders drugs
September 27, 2019
For patients with mental health (MH) or substance use (SU) disorders with newly diagnosed diabetes, primary care engagement may offer moderate health benefits, according to a study published online in JAMA Network Open.
FDA approves oral semaglutide Rybelsus to treat type 2 diabetes pharmaceutical-technology
September 26, 2019
FDA approval comes from results from ten PIONEER clinical trials conducted in a total of 9,543 adult type 2 diabetes patients.
Older Diabetics May Be Getting Too Much Insulin drugs
September 26, 2019
A new study suggests that's so: Older, sicker patients tend to be the ones most likely to still be using insulin to manage their blood sugar, despite guidelines that suggest it's often safer to ...
CHMP recommends AstraZeneca’s Qtrilmet for type 2 diabetes pharmaceutical-technology
September 25, 2019
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the marketing authorisation of AstraZeneca’s Qtrilmet to treat type 2 diabetes in adults.
First oral GLP-1 treatment for type 2 diabetes approved europeanpharmaceuticalreview
September 24, 2019
With the approval of the treatment, Rybelsus, there is a new option for treating type 2 diabetes without injections.
Dapagliflozin Lowers Risk for Worsening Heart Failure drugs
September 24, 2019
For patients with heart failure and reduced ejection fraction, dapagliflozin is associated with a lower risk for worsening heart failure or death from cardiovascular causes, regardless of the presence of type 2 diabetes ...
Higher Fat Mass May Up Risk for Major Adverse CV Events in T2DM drugs
September 24, 2019
In patients with type 2 diabetes, higher fat mass is associated with a higher risk for major adverse cardiovascular events ...
FDA Approves Rybelsus (semaglutide), the First Oral GLP-1 Analog Treatment for Adults with Type 2 Diabetes drugs
September 23, 2019
Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) has approved Rybelsus (semaglutide) tablets 7 mg or 14 mg for adults with type 2 diabetes that along with diet and exercise may improve blood sugar (glucose).
Linagliptin Noninferior for CV Risk in Early Type 2 Diabetes drugs
September 20, 2019
According to a study published online Sept. 19 in the Journal of the American Medical Association to coincide with the annual meeting of the European Association for the Study of Diabetes ...
These Diets Helped Women With Diabetes Cut Heart Attack, Stroke Risk drugs
September 20, 2019
Eating patterns similar to the Mediterranean diet and the blood pressure-lowering DASH may help older women with Type 2 diabetes ward off heart attacks, strokes and related problems, new research suggests.